Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis' Pluvicto.
from Business News https://ift.tt/u7F6RdN
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
0
